Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer
Clinical trial NCT06051851 · UNKNOWN
Trial details
- NCT number
- NCT06051851
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2025-07-01
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.